Jul. 8 at 9:51 AM
$ANIX
Anixa management has stated that the TNBC vaccine/therapy will actually be considered a Phase II/III trial, meaning that if the Phase II trial really shows curative results with no adverse effects, they will apply to have the Phase II turned into a Phase III trial. I don't know the procedural steps involved, but leave that to Anixa management to figure out. Remember, the goal is to prove efficacy, so big pharma partners with them. Same Phase II/III approach goes for the ovarian cancer therapy which is already showing incredible results. FDA is agreeable to compassionate use for people outside trials, especially when there are zero side effects!
